Synthon Hispania, S.L. (batch release, quality control (physico-chemical))

Ukraine

All drugs from this manufacturer

  • BONEVISTA

    The drug is intended for the treatment of osteoporosis in postmenopausal women who are at an increased risk of fractures.

    Dosage form: solution for injection

    Active substance Dosage
    ibandronic acid 1 mg/ml

    ATC: M05BA06